$4.20
-0.50-10.64%
At close: Jun 12, 5:00 PM EST
$5.05
0.8520.24%
After Hours: Jun 11, 7:40 AM EST
Quoin Pharmaceuticals Ltd Analyst Ratings
QNRXNASDAQ
Quoin Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:QNRX | Benzinga
Quoin Pharmaceuticals Ltd has a consensus price target of $17 based on the ratings of 2 analysts. The high is $30 issued by LUCID CAPITAL MARKETS on May 4, 2026. The low is $4 issued by Maxim Group on March 15, 2024. The 2 most-recent analyst ratings were released by LUCID CAPITAL MARKETS and Maxim Group on May 4, 2026 and March 15, 2024, respectively. With an average price target of $17 between LUCID CAPITAL MARKETS and Maxim Group, there's an implied 236.63% upside for Quoin Pharmaceuticals Ltd from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
LUCID CAPITAL MARKETS
Maxim Group
1calculated from analyst ratings
Analyst Ratings for Quoin Pharmaceuticals
Loading calendar...
FAQ
What is the target price for Quoin Pharmaceuticals (QNRX) stock?
The latest price target for Quoin Pharmaceuticals (NASDAQ:QNRX) was reported by LUCID CAPITAL MARKETS on May 4, 2026. The analyst firm set a price target for $30.00 expecting QNRX to rise to within 12 months (a possible 494.06% upside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Quoin Pharmaceuticals (QNRX)?
The latest analyst rating for Quoin Pharmaceuticals (NASDAQ:QNRX) was provided by LUCID CAPITAL MARKETS, and Quoin Pharmaceuticals initiated their buy rating.
When was the last upgrade for Quoin Pharmaceuticals (QNRX)?
There is no last upgrade for Quoin Pharmaceuticals
When was the last downgrade for Quoin Pharmaceuticals (QNRX)?
There is no last downgrade for Quoin Pharmaceuticals.
When is the next analyst rating going to be posted or updated for Quoin Pharmaceuticals (QNRX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Quoin Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Quoin Pharmaceuticals was filed on May 4, 2026 so you should expect the next rating to be made available sometime around May 4, 2027.
Is the Analyst Rating Quoin Pharmaceuticals (QNRX) correct?
While ratings are subjective and will change, the latest Quoin Pharmaceuticals (QNRX) rating was a initiated with a price target of $0.00 to $30.00. The current price Quoin Pharmaceuticals (QNRX) is trading at is $5.05, which is within the analyst’s predicted range.
